Actively hiring
Health Care
Plastics & Polymers
APIs & Drug Manufacturing
As featured in
Follow
Overview
News
Salaries
Products
People
Growth
Offices
Financials
Overview
Explore Curapath's support from preclinical to commercialization for non-viral drug delivery. Trust our expertise to transform patients' lives.
News
ABITEC and Curapath Sign Strategic Memorandum of Understanding (MOU)to Advance Next-Generation LNP Delivery Technologies
ABITEC n and Curapath have signed a strategic MOU expand access to custom lipids, PEG-free shielding technologies, and lipid nanoparticle (LNP) formulation.
Read more
Report
ABITEC and Curapath Sign Strategic Memorandum of Understanding (MOU) to Advance Next-Generation LNP Delivery Technologies
ABITEC Corporation and Curapath have signed a strategic MOU to expand access to high-purity custom lipids, PEG-free shielding technologies, and advanced lipid nanoparticle (LNP) formulation solutions.The collaboration brings together ABITEC's lipid chemis
Read more
Report
Curapath Joins the ARTHEx-Led Consortium for the NEUROAN Project to Advance Next-Generation RNA Therapeutics for Neuromuscular Diseases
Curapath is participating in the NEUROAN project, a strategic collaborative initiative led by ARTHEx Biotech that brings together ARTHEx Biotech, ProtoQSAR, AMS Biopharma and Curapath, to develop next-generation targeted RNA therapies for neuromuscular di
Read more
Report
Macro Biologics and Curapath Enhance Their Strategic Collaboration to Advance Amicidin-α Surgical Gel Toward Clinical Evaluation
Curapath is pleased to acknowledge the significant progress achieved by Macro Biologics, Inc., whose IND application for Amicidin-α Surgical Gel has been accepted by the FDA, enabling the initiation of the Phase 1 clinical trial. This milestone marks a de
Read more
Report
Curapath and Nacalai Tesque Partner to Expand Access to next generation Polymers and PEG-Free Shielding Lipids in Japan
Curapath has partnered with Nacalai Tesque to expand access to its portfolio of next-generation polymers and PEG-free shielding lipids for advanced drug delivery applications in Japan. This collaboration strengthens Curapath's global presence and enables
Read more
Report
Curapath and Nacalai Tesque Partner to Expand Access to next generation Polymers and PEG-Free Shielding Lipids in Japan
Read more
Report
Polymers in Drug Delivery: Shaping the Future of Advanced Therapeutics
Over the past two decades, polymer-based drug delivery systems have evolved from experimental concepts to clinically validated technologies, playing a key role in the development of next-generation therapeutics.At Curapath, with over 13 years of hands-on
Read more
Report
Curapath and Cristal Therapeutics Partner to Advance Next-Generation Targeted Drug Delivery with CliCr Bioconjugation Technology
At Curapath, we are committed to pushing the boundaries of polymer and lipid-based drug delivery. Today, we are excited to share that we have entered into a co-exclusive license agreement with Cristal Therapeutics to integrate their groundbreaking CliCr b
Read more
Report
Curapath renews its Crédit Impôt Recherche (CIR) accreditation for 2025
Curapath is proud to announce the renewal of its Crédit Impôt Recherche (CIR)accreditation up to 2027.Granted by the French Ministry of Higher Education and Research, this accreditationallows French companies collaborating with Curapath to continue benefi
Read more
Report
Curapath and Iris Biotech Partner to Provide Wider Access to Innovative Excipients for Drug Delivery
Curapath, a leading innovator in the design and manufacturing of polymer and lipid-based drug delivery systems, is proud to announce a strategic partnership with Iris Biotech, a global distributor of specialty reagents for drug development and delivery. T
Read more
Report
Show more news
